Surface modified nano-lipid drug conjugates of positive allosteric modulators of M1 muscarinic acetylcholine receptor for the treatment of Alzheimer’s disease-Reference-Cited by-同舟云学术

Surface modified nano-lipid drug conjugates of positive allosteric modulators of M1 muscarinic acetylcholine receptor for the treatment of Alzheimer’s disease

Published:2017-04 Issue: Volume:101 Page:17-22
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Chintamaneni Pavan Kumar,Krishnamurthy Praveen T.,Rao Pachava Vengal,Pindiprolu SaiKiran S.S.

Publisher

Elsevier BV

Subject

General Medicine

Reference61 articles.

1. Cognitive impairment: dementia and Alzheimer's disease;Larson;Annu Rev Public Health,1992

2. Alzheimer's disease facts and figures;Alzheimer’s;Alzheimers Dementia,2015

3. The case described by Alois Alzheimer in 1911;Möller;Eur Arch Psychiatry Clin Neurosci,1998

4. Alzheimer's disease: strategies for disease modification;Citron;Nat Rev Drug Discovery,2010

5. New subtypes of muscarinic acetylcholine receptors;Bonner;Trends Pharmacol Sci,1989

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysing the effect caused by increasing the molecular volume in M1-AChR receptor agonists and antagonists: a structural and computational study;RSC Advances;2024

2. Interplay between G protein-coupled receptors and nanotechnology;Acta Biomaterialia;2023-10

3. Engineered upconversion nanocarriers for synergistic breast cancer imaging and therapy: Current state of art;Journal of Controlled Release;2022-12

4. Nasal delivery of neurotherapeutics via nanocarriers: Facets, aspects, and prospects;Frontiers in Pharmacology;2022-09-13

5. Nanoneurology;Nanomaterials and Nanotechnology in Medicine;2022-09-09